Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-26-002045
Filing Date
2026-08-06
Accepted
2026-08-06 10:31:02
Documents
2
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7012
2 exhibit99.txt EX-99 2883
  Complete submission text file 0000315066-26-002045.txt   12018
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 0000

Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Subject) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-60487 | Film No.: 261247092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)